MORRISTOWN, N.J., Aug. 15, 2017 /PRNewswire/ -- Up to 5% of the
population suffer from facial Seborrheic Dermatitis (SD), a chronic
inflammatory skin disease affecting areas of the body that contain
larger numbers of sebaceous glands and, ultimately, resulting in
scaly, keratolytic (flakey), itchy, burning, and erythema (redness)
of the skin.1, 2 The potential impact of seborrheic
dermatitis is great on those who suffer from the diseases; it can
affect individuals both physically and emotionally.
Introducing Nutraseb™ Facial Cream, a new topical
prescription approach for multi-symptom management of facial
Seborrhea and Seborrheic Dermatitis. Nutraseb™ Facial Cream
is a steroid-free, fragrance free, water-based emulsion formulated
to target all four aspects of SD: inflammation, fungus, sebum, and
scaling.
"Nutraseb™ Facial Cream takes a 360-degree approach to manage
seborrheic dermatitis by demonstrating anti-inflammatory,
anti-fungal, sebum-reducing and scale-reducing properties," says
Dr. Deanne Mraz Robinson. "It
manages key components of Seborrheic Dermatitis and works to help
relieve dry, waxy skin, by maintaining a moist wound and skin
environment, which is beneficial to the healing process."
Nutraseb™ Facial Cream is backed by clinical data,
showcasing the efficacy and tolerance of the product in the
treatment of facial Seborrheic Dermatitis. Clinical results have
been previously presented3:
Study 1: Evaluation of the efficacy of Nutraseb™
Facial Cream in the treatment of mild facial Seborrheic
Dermatitis
- Nutraseb™ Facial Cream proved to be successful in 87.5% of
patients with mild dermatitis and 78.8% of patients considered the
cream to be good or excellent.
- Results of the study demonstrated the efficacy of Nutraseb™
Cream in 33 patients who were diagnosed with mild facial seborrheic
dermatitis.
- A significant number of patients had a decrease in
erythema.
Study 2: Assessing the ability of Nutraseb™ Facial Cream and
the cosmetic efficacy and cosmetic quality of the product
- Results of the study demonstrated that after 20 people used the
treatment for 21 days, more than 90% reported improvement of their
symptoms, with the added bonus of skin moisturization.
"The ISDIN brand is an emerging skincare staple in the U.S.
market leveraging our longstanding reputation in Spain and is pleased to be launching our very
first prescription product in the U.S." says, Robert D'Urso, US
Country Manager at ISDIN. "The introduction of Nutraseb™ Facial
Cream to the marketplace demonstrates the company's vision to
continually evolve and partner with Dermatologists to meet customer
needs."
1. Del Rosso JQ. Adult seborrheic dermatitis: a status report on
practical topical management. J Clin Aesthet Dermatol. 2011
May;4(5):32-8.
2. Goldenberg G. Optimizing treatment approaches in seborrheic
dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):44-9.
3. Data on file. Morristown, NJ
ISDIN Corp.: 2017
About Nutraseb™ Facial Cream
Nutraseb™ Facial Cream is contraindicated in persons with a known
hypersensitivity to any of the components of the formulation. For
topical use only. Avoid contact with eyes, not for ophthalmic use.
The safety and effectiveness of Nutraseb™ has not been tested on
subjects younger than age 22 years.
Keep out of the reach of children. Use only as directed.
Nutraseb™ does not contain a sunscreen, use of sunscreen products
and protective clothing over treated areas is recommended when
exposure cannot be avoided. If condition does not improve within
10-14 days, consult a physician. For full prescribing information
please visit www.nutraseb.com or see the supplied package
insert.
About ISDIN Corp.®
Founded in
1975 and headquartered in Barcelona,
Spain, ISDIN® is a Spanish dermatology company
with a 40-year history. It is jointly set up by the international
business groups, Puig and Esteve, benchmarks both in the cosmetic,
fashion and beauty, and pharmaceutical industries respectively. As
a multinational company, ISDIN® is committed to offering
holistic skin care solutions with its portfolio of treatment and
adjuvant therapy products to meet major dermatological needs and
solve dermatological problems. Constant innovation and research
share a common objective: development of products at the forefront
of dermatology, advanced formulas and new textures. Having enjoyed
rapid development since it was founded, ISDIN® nowadays
leads the skincare sector and is the #1 dermatological brand in
Spain.
ISDIN® is present mainly across Europe, Latin
America, North America and
South Africa with sales in over 30
countries. This includes Spain,
France, Belgium, Portugal, Chile, Mexico, Brazil, Argentina, South
Korea, and now, China and
the US. ISDIN® is trusted and recommended by
dermatologists worldwide and has enjoyed great popularity among
consumers all over the world for 40 years®.
ISDIN Corp. Morristown, NJ
862-242-8129
Nutraseb is a trademark of ISDIN Corp.
NUB-0717-0011
For media inquiries or additional information on the clinical
studies on Nutraseb™ Facial Cream, please contact the
below.
Media Contacts:
EvolveMKD
Ph: 646-517-4220
Email: ISDIN@EvolveMKD.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/isdin-corp-launches-new-non-steroidal-treatment-approach-for-facial-seborrheic-dermatitis-300504495.html
SOURCE ISDIN Corp.